Evofem Biosciences, Inc.
EVFM
$0.0097
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -8.86M | -7.94M | 60.43M | 50.52M |
| Total Depreciation and Amortization | 866.00K | 649.00K | 348.00K | 78.00K | 244.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.67M | 3.46M | -1.68M | -70.44M | -64.90M |
| Change in Net Operating Assets | 3.45M | 867.00K | 7.63M | 6.38M | 10.23M |
| Cash from Operations | -3.45M | -3.89M | -1.65M | -3.55M | -3.91M |
| Capital Expenditure | 0.00 | -14.00K | -14.00K | -14.00K | -15.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -612.00K | -555.00K | -509.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -612.00K | -569.00K | -523.00K | -14.00K | -15.00K |
| Total Debt Issued | 397.00K | 397.00K | 775.00K | 3.90M | 4.00M |
| Total Debt Repaid | -917.00K | -782.00K | -669.00K | -1.41M | -1.15M |
| Issuance of Common Stock | 5.00M | 5.00M | 116.00K | 130.00K | 229.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.26M | 1.26M | 1.26M | -- | -- |
| Repurchase of Preferred Stock | -1.26M | -1.26M | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 1.00M | 1.00M | -- |
| Cash from Financing | 4.48M | 4.62M | 2.48M | 3.62M | 3.08M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 420.00K | 161.00K | 312.00K | 56.00K | -845.00K |